London, United Kingdom–(Newsfile Corp. – December 17, 2024) – Edison issues report on Mendus (OMX: IMMU) Mendus continues to make headway with its lead programme assessing cancer vaccine vididencel as a potential maintenance therapy for acute myeloid leukaemia (AML), with the latest update presented at the 66th annual American Society of Hematology (ASH) meeting in […]